Who is eligible for GLP-1 in the US?
A MedVita in-depth guide, reviewed by our clinical team
GLP-1 medication can be a powerful tool for weight loss, but it’s not for everyone. If you’re trying to figure out whether you can get GLP-1 in the US, this guide walks through the prescribing rules, BMI thresholds, who’s typically considered, who isn’t, and the cost and insurance reality.
This guide is general information, not medical advice. Only a state-licensed clinician can decide whether GLP-1 treatment is appropriate for you, after reviewing your full health history.
What are the US rules for prescribing GLP-1 for weight loss?
GLP-1 medication in the US sits under three key rules:
- Prescription-only. Every GLP-1 medication available in the US is a prescription-only medicine. You cannot legally buy it over the counter or import it for personal use.
- State-licensed prescriber. Only clinicians licensed in your state can prescribe it, and they must perform a proper assessment first.
- Licensed pharmacy. Medication must be dispensed by a pharmacy licensed to operate in the US.
Clinicians also work within FDA-approved indications and accepted clinical guidelines. Some medications are approved for weight management (e.g. Wegovy, Zepbound, Saxenda); others, like Ozempic, are approved for type 2 diabetes and may sometimes be considered off-label by a clinician where clinically appropriate.
Telehealth services such as MedVita work entirely within this framework: a state-licensed clinician assesses you, a licensed U.S. pharmacy dispenses any prescribed medication.
Who is eligible for GLP-1 weight loss treatment in the US?
There’s no single eligibility checklist, but most clinicians in the US consider GLP-1 treatment for adults who:
- Have a higher BMI, or a moderate BMI with weight-related conditions.
- Have struggled to lose weight or keep it off through diet and exercise alone.
- Have weight-related health conditions such as type 2 diabetes, prediabetes, high blood pressure, high cholesterol, sleep apnea, fatty liver, or polycystic ovary syndrome (PCOS).
- Are ready to combine medication with healthier habits and ongoing care.
- Do not have medical reasons to avoid GLP-1 (covered further below).
A clinician weighs these together, not any one in isolation.
What BMI do I need to qualify for GLP-1 in the US?
The US uses the standard BMI categories defined by the CDC and WHO, which apply across the general adult population:
| BMI | Category |
|---|---|
| Below 18.5 | Underweight |
| 18.5–24.9 | Healthy range |
| 25.0–29.9 | Overweight |
| 30.0 and above | Obesity |
In practice, clinicians in the US typically consider GLP-1 weight loss treatment at a BMI of 30 and above, or a BMI of 27 and above when at least one weight-related condition is present (such as high blood pressure, type 2 diabetes, high cholesterol or obstructive sleep apnea). BMI alone does not decide eligibility, and a clinician will explain the trade-offs.
If you’d like to estimate your BMI now, our eligibility check calculates it for you using your height and weight.
Who should not take GLP-1 medication?
GLP-1 medication is generally not suitable for people who:
- Are pregnant, breastfeeding, or planning a pregnancy.
- Have a personal or family history of medullary thyroid cancer (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2).
- Have had pancreatitis.
- Are under 18 (pediatric use has specific separate considerations).
Several other conditions call for extra caution and may rule out treatment, including (but not limited to):
- Severe gastrointestinal conditions such as gastroparesis.
- Active cancer or recent cancer treatment.
- Active substance use disorders.
- Certain severe kidney, liver or thyroid conditions.
This is exactly what a proper screening is designed to catch — which is why honest answers in the assessment matter.
Is GLP-1 eligibility different for Wegovy, Zepbound, Saxenda and Ozempic?
Yes, partly. The eligibility principles (BMI, history, contraindications) are similar across GLP-1 medications, but the FDA-approved indication for each medicine is not the same:
- Wegovy (semaglutide) — FDA-approved for weight management.
- Zepbound (tirzepatide) — FDA-approved for weight management.
- Saxenda (liraglutide) — FDA-approved for weight management.
- Ozempic (semaglutide) and Mounjaro (tirzepatide) — FDA-approved for type 2 diabetes (and often used off-label for weight loss).
When a medication is being considered for an indication that isn’t its FDA-approved one (for example, semaglutide for weight loss outside the weight-management brand), a clinician will explain that and discuss whether it’s suitable. The medicine itself is the same molecule; the choice is about safety, suitability, supply and approval.
For a deeper comparison of how the medicines themselves differ, see our guide on semaglutide vs tirzepatide.
Will insurance or an HSA/FSA cover GLP-1 in the US?
For most people in the US, the honest answer is: it depends on your plan, and often coverage is limited. Here’s the lay of the land:
- Commercial and employer insurance. Some plans cover GLP-1 for weight management, but many exclude weight-loss medication or require prior authorization and documented criteria. Coverage for type 2 diabetes is more common than coverage for weight loss.
- Medicare and Medicaid. Medicare has historically not covered medication used solely for weight loss, though this is evolving; Medicaid coverage varies by state.
- HSA and FSA. You can typically use a Health Savings Account (HSA) or Flexible Spending Account (FSA) toward eligible out-of-pocket costs when GLP-1 is prescribed. Check your plan’s rules.
- Manufacturer savings cards. Drugmakers offer savings programs that can lower the price for eligible, commercially insured patients.
The result is that many patients in the US pay out of pocket for GLP-1 weight loss treatment, or use cash-pay telehealth pricing. This is partly why transparent monthly pricing matters: MedVita publishes indicative monthly plans, free nationwide delivery and no lock-in, so you know what you’re committing to.
How do I check if I’m eligible for GLP-1 in the US?
The clearest path is a structured assessment with a state-licensed clinician. With MedVita you can do this entirely online:
- Take the free online assessment — about a few minutes.
- A state-licensed clinician reviews your BMI, health history and goals — usually within one business day.
- You receive a personalized next step — if you’re suitable, a recommendation and prescription; if not, an honest explanation and any alternatives worth considering.
You’re not committing to anything by checking. The aim is to give you a clear answer rather than guessing.